Rapid Micro Biosystems to announce Q4 and full year 2024 financial results on February 28, 2025. Webcast at 8:00 a.m. ET. Rapid Micro Biosystems, Inc. will announce its fourth quarter and full year ...

LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation ...

The company reported Q1 2025 revenue of $7.2 million, reflecting a 28% increase compared to the previous year. Service revenue reached a quarterly record, growing 64% year-over-year. Gross margins ...

Robert Spignesi, CEO, opened by highlighting third quarter revenue of $7.8 million, which was above the midpoint of guidance and marked the twelfth consecutive quarter meeting or beating revenue ...

Rapid Micro Biosystems and Merck KGaA have signed a five-year global distribution agreement for Growth Direct systems and consumables. Rapid Micro Biosystems, Inc. has entered a five-year global ...

Rapid Micro Biosystems, Inc. reports earnings inline with expectations. Reported EPS is $-0.22 EPS, expectations were $-0.22. Operator: Thank you for standing by. My name is Eloisa, and I will be your ...

Included a multi-system order at an additional site of an existing top 20 global pharma customer as part of their global Growth Direct system rollout Achieved inflection in gross margins to positive 8 ...

LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation ...